ASENAPINE MALEATE

ASENAPINE MALEATE was reported 8672 times

ASENAPINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANOSOGNOSIA 426 0.5547
1 BLOOD PROLACTIN ABNORMAL 415 0.4809
2 DOPAMINE SUPERSENSITIVITY PSYCHOSIS 4 0.2500
3 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 151 0.2185
4 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 25 0.2000
5 DISTURBANCE IN SOCIAL BEHAVIOUR 413 0.1751
6 DISINHIBITION 152 0.0944
7 MUCOSAL EXCORIATION 4 0.0930
8 METABOLIC DISORDER 416 0.0716
9 THERMAL BURNS OF EYE 15 0.0664
10 BULBOSPINAL MUSCULAR ATROPHY CONGENITAL 2 0.0465
11 CARDIOMETABOLIC SYNDROME 4 0.0421
12 PERSONALITY CHANGE 387 0.0416
13 SEXUAL DYSFUNCTION 437 0.0372
14 THERAPEUTIC PRODUCT EFFECT VARIABLE 143 0.0368
15 THYROIDITIS ACUTE 5 0.0350
16 EMOTIONAL POVERTY 58 0.0331
17 AKATHISIA 419 0.0307
18 SCHIZOPHRENIA 328 0.0270
19 SEDATION 705 0.0269
20 DYSTONIA 522 0.0269
21 MANIC SYMPTOM 4 0.0238
22 SCHIZOAFFECTIVE DISORDER 42 0.0235
23 SELF ESTEEM INFLATED 3 0.0234
24 COGWHEEL RIGIDITY 24 0.0229
25 OBSESSIVE-COMPULSIVE DISORDER 181 0.0225
26 HYPOAESTHESIA ORAL 339 0.0225
27 ORTHOSTATIC HYPERTENSION 13 0.0223
28 PHARYNGEAL HYPOAESTHESIA 20 0.0215
29 PANCREATIC STEATOSIS 5 0.0184
30 VASCULAR DEMENTIA 16 0.0182
31 HEAD TITUBATION 25 0.0182
32 ACID BASE BALANCE ABNORMAL 4 0.0179
33 EUPHORIC MOOD 172 0.0168
34 DYSLIPIDAEMIA 85 0.0167
35 SELECTIVE EATING DISORDER 15 0.0165
36 SOLILOQUY 14 0.0162
37 SOCIAL ANXIETY DISORDER 10 0.0152
38 SEDATION COMPLICATION 37 0.0145
39 TONGUE BLISTERING 32 0.0143
40 DISSOCIATIVE IDENTITY DISORDER 3 0.0143
41 TONGUE EXFOLIATION 5 0.0142
42 TOOTH DISCOLOURATION 41 0.0139
43 WATER INTOXICATION 7 0.0138
44 OROPHARYNGEAL BLISTERING 22 0.0135
45 PRODUCT BLISTER PACKAGING ISSUE 14 0.0135
46 DYSKINESIA 535 0.0132
47 MICROCYTOSIS 3 0.0121
48 BIPOLAR I DISORDER 26 0.0118
49 ALCOHOL USE DISORDER 2 0.0117
50 ANXIETY DISORDER 39 0.0117
51 ACTIVATION SYNDROME 4 0.0116
52 ANTICHOLINERGIC SYNDROME 18 0.0113
53 DEPENDENT PERSONALITY DISORDER 2 0.0110
54 SUICIDE ATTEMPT 665 0.0110
55 CHANGE IN SEIZURE PRESENTATION 7 0.0108
56 INCREASED APPETITE 205 0.0107
57 BIFASCICULAR BLOCK 2 0.0107
58 INTENTION TREMOR 6 0.0105
59 PROTRUSION TONGUE 6 0.0103
60 VISCERAL CONGESTION 5 0.0098
61 LABELLED DRUG-DRUG INTERACTION ISSUE 14 0.0097
62 DELUSIONAL PERCEPTION 4 0.0096
63 OROMANDIBULAR DYSTONIA 7 0.0096
64 TONGUE SPASM 3 0.0096
65 LEUKAEMIA 89 0.0094
66 CATAPLEXY 13 0.0092
67 TONGUE ULCERATION 31 0.0092
68 BREATH ALCOHOL TEST POSITIVE 2 0.0089
69 DISTRACTIBILITY 10 0.0087
70 RADIAL NERVE PALSY 3 0.0085
71 PATIENT UNCOOPERATIVE 4 0.0084
72 AGNOSIA 2 0.0084
73 OCULOGYRIC CRISIS 18 0.0084
74 PERIODIC LIMB MOVEMENT DISORDER 3 0.0082
75 MANIA 134 0.0081
76 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 564 0.0079
77 AUTOPHOBIA 2 0.0079
78 HALLUCINATION, AUDITORY 124 0.0078
79 PRODUCT BARCODE ISSUE 3 0.0078
80 MYASTHENIC SYNDROME 6 0.0078
81 RESTING TREMOR 5 0.0077
82 FEELINGS OF WORTHLESSNESS 10 0.0077
83 ABULIA 7 0.0076
84 CULTURE STOOL POSITIVE 2 0.0073
85 STERNAL FRACTURE 9 0.0073
86 THERAPEUTIC PRODUCT INEFFECTIVE 27 0.0070
87 DROOLING 48 0.0069
88 NEPHROGENIC DIABETES INSIPIDUS 8 0.0069
89 TACHYPHRENIA 24 0.0069
90 ELEVATED MOOD 3 0.0069
91 PERSONALITY DISORDER 18 0.0069
92 ENURESIS 27 0.0067
93 BANKRUPTCY 3 0.0067
94 PLEUROTHOTONUS 6 0.0066
95 BINGE EATING 7 0.0065
96 PULMONARY VALVE INCOMPETENCE 9 0.0062
97 EXTRAPYRAMIDAL DISORDER 151 0.0061
98 TONGUE ERUPTION 3 0.0060
99 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 3 0.0060
100 PERSONAL RELATIONSHIP ISSUE 4 0.0060
101 HYPOMANIA 22 0.0060
102 ORAL MUCOSAL EXFOLIATION 9 0.0059
103 BLOOD PROLACTIN INCREASED 28 0.0059
104 PRODUCT SOLUBILITY ABNORMAL 29 0.0057
105 INCORRECT ROUTE OF DRUG ADMINISTRATION 205 0.0057
106 INAPPROPRIATE AFFECT 9 0.0057
107 MYOCARDITIS 65 0.0057
108 BORDERLINE PERSONALITY DISORDER 4 0.0056
109 ORAL DISCOMFORT 77 0.0055
110 POLYDIPSIA 21 0.0053
111 FEELING GUILTY 7 0.0053
112 OBESITY 84 0.0053
113 INSURANCE ISSUE 80 0.0052
114 BURN ORAL CAVITY 3 0.0052
115 QRS AXIS ABNORMAL 4 0.0052
116 GRIMACING 4 0.0051
117 PRODUCT TASTE ABNORMAL 68 0.0050
118 DYSMETRIA 3 0.0050
119 SWOLLEN TONGUE 155 0.0050
120 RESTLESS LEGS SYNDROME 90 0.0049
121 PARKINSONISM 48 0.0049
122 UNDERDOSE 353 0.0048
123 EMBOLIC STROKE 17 0.0048
124 GAMBLING DISORDER 13 0.0048
125 OESOPHAGEAL RUPTURE 4 0.0048
126 CEREBRAL ATROPHY 19 0.0048
127 EXCESSIVE EYE BLINKING 7 0.0047
128 PREMATURE EJACULATION 3 0.0047
129 SELF-DESTRUCTIVE BEHAVIOUR 4 0.0046
130 DYSGEUSIA 337 0.0045
131 FACIAL SPASM 5 0.0045
132 DELUSION OF GRANDEUR 2 0.0045
133 GLOSSODYNIA 99 0.0044
134 PRESCRIBED OVERDOSE 84 0.0043
135 HOSTILITY 11 0.0043
136 SUDDEN ONSET OF SLEEP 6 0.0043
137 NEUROLEPTIC MALIGNANT SYNDROME 51 0.0043
138 PSYCHOGENIC SEIZURE 4 0.0043
139 SUSPICIOUSNESS 3 0.0043
140 APPLICATION SITE ULCER 3 0.0042
141 SALIVARY HYPERSECRETION 42 0.0042
142 SOMNAMBULISM 27 0.0041
143 NEGATIVE THOUGHTS 12 0.0041
144 PSYCHIATRIC DECOMPENSATION 8 0.0041
145 GALACTORRHOEA 26 0.0040
146 FEELING DRUNK 30 0.0040
147 TONGUE DISCOMFORT 17 0.0040
148 DELUSION 62 0.0040
149 LOGORRHOEA 14 0.0040
150 REDUCED FACIAL EXPRESSION 4 0.0039
151 EYE MOVEMENT DISORDER 27 0.0039
152 POLYHYDRAMNIOS 4 0.0039
153 APHTHOUS STOMATITIS 9 0.0039
154 MICROCYTIC ANAEMIA 8 0.0038
155 PRODUCT INEFFECTIVE 3 0.0038
156 AUTOSCOPY 2 0.0037
157 GLOSSITIS 13 0.0037
158 BLOOD INSULIN INCREASED 2 0.0036
159 PERSECUTORY DELUSION 9 0.0036
160 ANTICONVULSANT DRUG LEVEL DECREASED 5 0.0035
161 DRUG EFFECT VARIABLE 4 0.0035
162 TARDIVE DYSKINESIA 99 0.0035
163 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 25 0.0035
164 PARANOIA 59 0.0034
165 DYSPHEMIA 15 0.0034
166 PSYCHOTIC DISORDER 101 0.0034
167 COMPULSIVE SHOPPING 7 0.0034
168 PSYCHOTIC SYMPTOM 7 0.0034
169 SUICIDAL BEHAVIOUR 14 0.0034
170 PHYSICAL ASSAULT 7 0.0033
171 LISTLESS 11 0.0033
172 WEIGHT ABNORMAL 8 0.0033
173 TONGUE DISORDER 24 0.0033
174 HYPERSEXUALITY 6 0.0033
175 DISTURBANCE IN SEXUAL AROUSAL 3 0.0033
176 ACUTE PSYCHOSIS 8 0.0032
177 SEROTONIN SYNDROME 62 0.0032
178 SLEEP-RELATED EATING DISORDER 3 0.0032
179 LEUKOPENIA 152 0.0030
180 ILLUSION 5 0.0030
181 PSYCHOTIC BEHAVIOUR 3 0.0030
182 RESTLESSNESS 106 0.0029
183 SELF-INJURIOUS IDEATION 12 0.0029
184 BIPOLAR DISORDER 31 0.0028
185 TORTICOLLIS 6 0.0028
186 BITE 2 0.0028
187 OEDEMA MOUTH 9 0.0028
188 ORAL DISORDER 20 0.0027
189 PRE-EXISTING CONDITION IMPROVED 17 0.0027
190 HOMICIDAL IDEATION 11 0.0027
191 PSYCHIATRIC SYMPTOM 20 0.0027
192 CENTRAL OBESITY 2 0.0027
193 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
194 AMPHETAMINES POSITIVE 2 0.0027
195 PRIAPISM 9 0.0026
196 FLAT AFFECT 6 0.0026
197 ORAL MUCOSAL ERYTHEMA 4 0.0026
198 CONVERSION DISORDER 5 0.0026
199 BLOOD GLUCOSE INCREASED 485 0.0026
200 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
201 DEPRESSIVE SYMPTOM 9 0.0026
202 PHARYNGEAL OEDEMA 39 0.0025
203 WEIGHT INCREASED 566 0.0025
204 AGITATION 185 0.0025
205 SUICIDAL IDEATION 229 0.0025
206 CATATONIA 13 0.0025
207 COMPULSIVE SEXUAL BEHAVIOUR 2 0.0025
208 METABOLIC SYNDROME 4 0.0024
209 SELF-MEDICATION 10 0.0024
210 BLOOD UREA DECREASED 3 0.0024
211 BRUXISM 13 0.0024
212 CONGESTIVE CARDIOMYOPATHY 10 0.0024
213 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
214 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 169 0.0024
215 JAW DISORDER 13 0.0024
216 ANGLE CLOSURE GLAUCOMA 6 0.0023
217 APTYALISM 2 0.0023
218 RESPIRATION ABNORMAL 16 0.0023
219 LOSS OF EMPLOYMENT 7 0.0023
220 PHARYNGEAL ULCERATION 3 0.0023
221 NYSTAGMUS 12 0.0023
222 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0022
223 PSYCHOMOTOR HYPERACTIVITY 37 0.0022
224 MUSCLE TWITCHING 51 0.0022
225 CLUSTER HEADACHE 3 0.0022
226 CLONUS 6 0.0022
227 COLOUR BLINDNESS 2 0.0022
228 ANTIPSYCHOTIC DRUG LEVEL INCREASED 6 0.0021
229 GUN SHOT WOUND 4 0.0021
230 THINKING ABNORMAL 39 0.0021
231 HALLUCINATION, VISUAL 44 0.0021
232 TONGUE DISCOLOURATION 9 0.0021
233 SLEEP PARALYSIS 3 0.0020
234 MOUTH ULCERATION 43 0.0020
235 TIC 11 0.0020
236 HYPOAESTHESIA FACIAL 3 0.0020
237 HANGOVER 7 0.0020
238 FOAMING AT MOUTH 4 0.0020
239 LIBIDO INCREASED 4 0.0020
240 SELF INJURIOUS BEHAVIOUR 6 0.0020
241 IRRITABILITY 118 0.0020
242 HUNGER 27 0.0019
243 VIOLENCE-RELATED SYMPTOM 3 0.0019
244 TRISMUS 10 0.0019
245 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
246 COMPLETED SUICIDE 158 0.0019
247 IMPULSIVE BEHAVIOUR 7 0.0019
248 DEREALISATION 4 0.0019
249 SNORING 7 0.0018
250 LANGUAGE DISORDER 4 0.0018
251 ABNORMAL BEHAVIOUR 72 0.0018
252 ANGER 61 0.0018
253 PANIC REACTION 13 0.0018
254 DYSARTHRIA 67 0.0018
255 MAJOR DEPRESSION 13 0.0018
256 WRONG TECHNIQUE IN DRUG USAGE PROCESS 64 0.0018
257 HYPERCHOLESTEROLAEMIA 17 0.0018
258 ADVERSE DRUG REACTION 158 0.0018
259 MUSCLE RIGIDITY 21 0.0018
260 HYPERPHAGIA 7 0.0018
261 ELECTROCARDIOGRAM QT PROLONGED 63 0.0017
262 FORMICATION 12 0.0017
263 BREAST DISCHARGE 3 0.0017
264 IMPRISONMENT 3 0.0017
265 BRADYPHRENIA 11 0.0017
266 PULSE ABSENT 8 0.0017
267 OBSESSIVE THOUGHTS 3 0.0017
268 SOMNOLENCE 329 0.0016
269 CHOKING SENSATION 9 0.0016
270 LOCAL SWELLING 28 0.0016
271 IMMOBILE 7 0.0016
272 GASTROINTESTINAL TUBE INSERTION 4 0.0016
273 PARAESTHESIA ORAL 23 0.0016
274 LIP DISORDER 3 0.0016
275 TOXICITY TO VARIOUS AGENTS 263 0.0016
276 ASPIRATION 17 0.0016
277 PANIC DISORDER 6 0.0015
278 MUSCLE TIGHTNESS 25 0.0015
279 AGGRESSION 77 0.0015
280 SPEECH DISORDER 79 0.0015
281 POST-TRAUMATIC STRESS DISORDER 10 0.0015
282 SINUS TACHYCARDIA 21 0.0015
283 LIP BLISTER 4 0.0015
284 EYELID OEDEMA 17 0.0015
285 CONVULSION 83 0.0014
286 AKINESIA 3 0.0014
287 DENTAL CARIES 16 0.0014
288 CHRONIC FATIGUE SYNDROME 2 0.0014
289 SLEEP DEFICIT 3 0.0014
290 BUNDLE BRANCH BLOCK LEFT 6 0.0014
291 GRANULOCYTOPENIA 8 0.0014
292 DRUG SCREEN POSITIVE 11 0.0014
293 INCOHERENT 9 0.0014
294 ORAL PAIN 31 0.0014
295 SOCIAL AVOIDANT BEHAVIOUR 8 0.0014
296 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
297 ALCOHOL USE 5 0.0014
298 APRAXIA 2 0.0013
299 ASPHYXIA 11 0.0013
300 THERAPY NON-RESPONDER 60 0.0013
301 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
302 MASTICATION DISORDER 4 0.0013
303 NIGHTMARE 45 0.0013
304 IRON DEFICIENCY ANAEMIA 12 0.0013
305 PRODUCT RESIDUE PRESENT 7 0.0013
306 DAYDREAMING 2 0.0013
307 APPLICATION SITE REACTION 9 0.0013
308 PROSTATOMEGALY 5 0.0013
309 AFFECTIVE DISORDER 10 0.0013
310 ORTHOSTATIC HYPOTENSION 22 0.0013
311 BLADDER PAIN 4 0.0013
312 TRICUSPID VALVE INCOMPETENCE 10 0.0013
313 URINARY HESITATION 3 0.0013
314 APHAGIA 6 0.0012
315 VENTRICULAR HYPOKINESIA 4 0.0012
316 STUPOR 4 0.0012
317 CONDITION AGGRAVATED 378 0.0012
318 STARING 3 0.0012
319 SELF ESTEEM DECREASED 3 0.0012
320 PANIC ATTACK 45 0.0012
321 HALLUCINATION 93 0.0012
322 IMPAIRED DRIVING ABILITY 14 0.0012
323 THIRST 22 0.0012
324 POSTURE ABNORMAL 4 0.0012
325 POLYURIA 10 0.0012
326 BREAST ENLARGEMENT 4 0.0012
327 PENIS DISORDER 3 0.0012
328 HYPERNATRAEMIA 6 0.0012
329 HYPERPARATHYROIDISM SECONDARY 3 0.0012
330 LEFT VENTRICULAR DYSFUNCTION 8 0.0012
331 DISORIENTATION 47 0.0012
332 ENERGY INCREASED 7 0.0012
333 ATAXIA 14 0.0012
334 DISSOCIATION 9 0.0012
335 INITIAL INSOMNIA 12 0.0012
336 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
337 VIITH NERVE PARALYSIS 4 0.0012
338 MENTAL IMPAIRMENT 28 0.0012
339 URINE OUTPUT INCREASED 3 0.0011
340 INSOMNIA 304 0.0011
341 FOOD CRAVING 6 0.0011
342 AGEUSIA 28 0.0011
343 ALCOHOL ABUSE 3 0.0011
344 FRUSTRATION 4 0.0011
345 BREAST SWELLING 3 0.0011
346 LARYNGOSPASM 3 0.0011
347 BRADYPNOEA 3 0.0011
348 URINARY TRACT DISORDER 5 0.0011
349 MONOCYTE COUNT INCREASED 4 0.0011
350 SCREAMING 7 0.0011
351 HICCUPS 9 0.0011
352 PRODUCT PRESCRIBING ERROR 26 0.0011
353 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
354 HYPERSOMNIA 31 0.0011
355 HYPERPROLACTINAEMIA 7 0.0011
356 ACCIDENTAL DEATH 2 0.0011
357 OEDEMA PERIPHERAL 131 0.0011
358 BLOOD CHOLESTEROL DECREASED 2 0.0011
359 PSYCHOMOTOR RETARDATION 3 0.0011
360 MOVEMENT DISORDER 34 0.0011
361 AUTOIMMUNE THYROIDITIS 4 0.0011
362 FEELING JITTERY 20 0.0010
363 TONGUE OEDEMA 4 0.0010
364 COMMUNICATION DISORDER 4 0.0010
365 FAECAL INCONTINENCE 5 0.0010
366 HYPERVENTILATION 6 0.0010
367 DYSPHAGIA 98 0.0010
368 SENSATION OF HEAVINESS 4 0.0010
369 TREMOR 171 0.0010
370 CONJUNCTIVITIS 19 0.0010
371 FEELING OF BODY TEMPERATURE CHANGE 6 0.0010
372 STRABISMUS 3 0.0010
373 BRADYKINESIA 6 0.0010
374 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
375 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
376 SWELLING FACE 66 0.0010
377 EXPIRED DRUG ADMINISTERED 5 0.0010
378 CREPITATIONS 3 0.0010
379 DEPRESSION 227 0.0010
380 STOMATITIS 60 0.0010
381 EMBOLISM VENOUS 3 0.0010
382 CHANGE OF BOWEL HABIT 2 0.0010
383 CHOKING 19 0.0010
384 ANXIETY 276 0.0010
385 TEMPERATURE INTOLERANCE 10 0.0010
386 THROAT TIGHTNESS 26 0.0010
387 BODY TEMPERATURE FLUCTUATION 2 0.0010
388 APATHY 14 0.0010
389 OEDEMA 52 0.0010
390 LACERATION 9 0.0010
391 BLEPHAROSPASM 6 0.0010
392 TESTICULAR PAIN 3 0.0009
393 INTENTIONAL SELF-INJURY 19 0.0009
394 EATING DISORDER 20 0.0009
395 TOOTHACHE 17 0.0009
396 DRUG PRESCRIBING ERROR 18 0.0009
397 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
398 TREATMENT NONCOMPLIANCE 51 0.0009
399 ADVERSE EVENT 85 0.0009
400 MONOPLEGIA 4 0.0009
401 MOOD ALTERED 25 0.0009
402 AMENORRHOEA 16 0.0009
403 NONSPECIFIC REACTION 5 0.0009
404 APPETITE DISORDER 6 0.0009
405 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
406 MENTAL DISORDER 39 0.0009
407 LOSS OF LIBIDO 8 0.0009
408 DRUG INTERACTION 141 0.0009
409 EMOTIONAL DISORDER 27 0.0009
410 EXERCISE TOLERANCE DECREASED 5 0.0009
411 FEELING ABNORMAL 208 0.0009
412 HYPERREFLEXIA 3 0.0009
413 COORDINATION ABNORMAL 12 0.0009
414 SUBSTANCE ABUSE 7 0.0009
415 ECONOMIC PROBLEM 13 0.0009
416 FEELING OF DESPAIR 4 0.0009
417 SUSPECTED SUICIDE 4 0.0009
418 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
419 UNRESPONSIVE TO STIMULI 22 0.0009
420 NEONATAL RESPIRATORY DISTRESS SYNDROME 3 0.0008
421 URINARY INCONTINENCE 25 0.0008
422 PRODUCT PACKAGING ISSUE 8 0.0008
423 URINARY RETENTION 28 0.0008
424 HYPOAESTHESIA 125 0.0008
425 SOPOR 11 0.0008
426 DYSSTASIA 24 0.0008
427 TENSION 5 0.0008
428 BREATH ODOUR 2 0.0008
429 GENERALISED OEDEMA 10 0.0008
430 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
431 FLUID INTAKE REDUCED 4 0.0008
432 DEPRESSED MOOD 42 0.0008
433 RHABDOMYOLYSIS 33 0.0008
434 DRUG TOLERANCE 4 0.0008
435 POOR QUALITY SLEEP 17 0.0008
436 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
437 CLAVICLE FRACTURE 3 0.0008
438 DRUG RESISTANCE 20 0.0008
439 DELIRIUM 27 0.0008
440 ANGIOEDEMA 34 0.0008
441 DEAFNESS 20 0.0008
442 OESOPHAGEAL PAIN 3 0.0008
443 DYSGRAPHIA 5 0.0008
444 INCONTINENCE 8 0.0008
445 LIVER FUNCTION TEST ABNORMAL 22 0.0008
446 MIOSIS 6 0.0007
447 GOITRE 3 0.0007
448 PRODUCT SUBSTITUTION ISSUE 42 0.0007
449 DISTURBANCE IN ATTENTION 39 0.0007
450 DIZZINESS POSTURAL 7 0.0007
451 HALLUCINATIONS, MIXED 3 0.0007
452 SLEEP DISORDER 50 0.0007
453 DIABETES MELLITUS 54 0.0007
454 MUSCLE FATIGUE 3 0.0007
455 NERVOUSNESS 37 0.0007
456 MITRAL VALVE INCOMPETENCE 8 0.0007
457 AORTIC VALVE INCOMPETENCE 3 0.0007
458 ALCOHOLISM 3 0.0007
459 AGRANULOCYTOSIS 13 0.0007
460 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
461 DRUG INEFFECTIVE 914 0.0007
462 MOOD SWINGS 22 0.0007
463 BLOOD SODIUM DECREASED 13 0.0007
464 MOTOR DYSFUNCTION 7 0.0007
465 MOUTH HAEMORRHAGE 5 0.0007
466 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
467 BLOOD CREATINE INCREASED 3 0.0007
468 FEAR 18 0.0007
469 WEIGHT FLUCTUATION 7 0.0007
470 ACNE CYSTIC 2 0.0007
471 MUSCULOSKELETAL STIFFNESS 58 0.0007
472 CRANIOCEREBRAL INJURY 2 0.0007
473 CRYING 24 0.0007
474 HYPOGLYCAEMIA 32 0.0007
475 RETCHING 14 0.0007
476 NO THERAPEUTIC RESPONSE 8 0.0007
477 LOSS OF CONSCIOUSNESS 84 0.0007
478 EAR DISORDER 3 0.0007
479 HYPERTHERMIA 5 0.0007
480 MENTAL STATUS CHANGES 18 0.0006
481 NEPHROGENIC ANAEMIA 3 0.0006
482 ABASIA 16 0.0006
483 YELLOW SKIN 3 0.0006
484 SYNCOPE 64 0.0006
485 BLOOD CREATININE DECREASED 2 0.0006
486 LIP SWELLING 21 0.0006
487 APHASIA 19 0.0006
488 PARALYSIS 9 0.0006
489 DRY MOUTH 51 0.0006
490 ATRIAL FLUTTER 5 0.0006
491 CONFUSIONAL STATE 101 0.0006
492 MYDRIASIS 8 0.0006
493 AFFECT LABILITY 6 0.0006
494 PRODUCT USE IN UNAPPROVED INDICATION 154 0.0006
495 RASH GENERALISED 16 0.0006
496 MUSCLE DISORDER 5 0.0006
497 APPLICATION SITE VESICLES 4 0.0006
498 HYPERTENSION 130 0.0006
499 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
500 PULMONARY CONGESTION 8 0.0006
501 PRODUCT FORMULATION ISSUE 4 0.0006
502 ADVERSE REACTION 8 0.0006
503 PRESCRIBED UNDERDOSE 12 0.0006
504 DYSPHORIA 3 0.0006
505 DIZZINESS 294 0.0006
506 MIDDLE INSOMNIA 11 0.0006
507 TACHYCARDIA 52 0.0006
508 ANHEDONIA 15 0.0006
509 BLOOD LACTIC ACID INCREASED 3 0.0006
510 SCRATCH 6 0.0006
511 HEART RATE INCREASED 56 0.0006
512 HEAD DISCOMFORT 10 0.0006
513 ILEUS 7 0.0006
514 BREAST PAIN 6 0.0006
515 IMPAIRED WORK ABILITY 12 0.0006
516 APPARENT DEATH 2 0.0006
517 PRURITUS GENERALISED 12 0.0006
518 DRUG EFFECT INCOMPLETE 20 0.0006
519 RESPIRATORY ARREST 15 0.0005
520 HYPERHIDROSIS 70 0.0005
521 CARDIOMYOPATHY 8 0.0005
522 STEVENS-JOHNSON SYNDROME 12 0.0005
523 STREPTOCOCCAL INFECTION 3 0.0005
524 COGNITIVE DISORDER 25 0.0005
525 BREAST TENDERNESS 4 0.0005
526 FLUID RETENTION 27 0.0005
527 DISEASE RECURRENCE 25 0.0005
528 ANAPHYLACTIC REACTION 29 0.0005
529 SLEEP APNOEA SYNDROME 10 0.0005
530 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
531 AMNESIA 34 0.0005
532 BOWEL MOVEMENT IRREGULARITY 4 0.0005
533 SINUS BRADYCARDIA 5 0.0005
534 HYPONATRAEMIA 29 0.0005
535 IMPAIRED GASTRIC EMPTYING 7 0.0005
536 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
537 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
538 POLLAKIURIA 21 0.0005
539 MYOCLONUS 6 0.0005
540 LEUKOCYTOSIS 9 0.0005
541 CELLULITIS 25 0.0005
542 FRUSTRATION TOLERANCE DECREASED 4 0.0005
543 NOCTURIA 6 0.0005
544 OFF LABEL USE 430 0.0005
545 RIB FRACTURE 10 0.0005
546 ANAPHYLACTOID REACTION 2 0.0005
547 DRUG DIVERSION 3 0.0005
548 DRUG ABUSE 40 0.0005
549 ACCIDENTAL EXPOSURE 2 0.0005
550 PNEUMONIA ASPIRATION 12 0.0005
551 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
552 TINNITUS 22 0.0005
553 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
554 WITHDRAWAL SYNDROME 20 0.0005
555 UNEVALUABLE EVENT 36 0.0005
556 FACE OEDEMA 8 0.0005
557 BALANCE DISORDER 41 0.0005
558 THERAPEUTIC RESPONSE CHANGED 3 0.0005
559 ABNORMAL DREAMS 13 0.0005
560 CARDIAC FAILURE CHRONIC 2 0.0005
561 RESPIRATORY DISORDER 14 0.0005
562 VITAMIN D DECREASED 4 0.0005
563 ROAD TRAFFIC ACCIDENT 19 0.0005
564 COLD SWEAT 8 0.0005
565 OVERDOSE 97 0.0004
566 CARDIAC ARREST 37 0.0004
567 FACIAL PAIN 4 0.0004
568 PRODUCT PHYSICAL ISSUE 9 0.0004
569 CYANOSIS 7 0.0004
570 FEEDING DISORDER 9 0.0004
571 OROPHARYNGEAL DISCOMFORT 4 0.0004
572 HEAD INJURY 14 0.0004
573 MUSCLE SPASMS 81 0.0004
574 MYOCARDIAL ISCHAEMIA 5 0.0004
575 BLOOD TESTOSTERONE DECREASED 3 0.0004
576 VISION BLURRED 60 0.0004
577 INTENTIONAL OVERDOSE 28 0.0004
578 INCREASED TENDENCY TO BRUISE 4 0.0004
579 LYMPHOEDEMA 3 0.0004
580 GRAND MAL CONVULSION 4 0.0004
581 EXTRASYSTOLES 3 0.0004
582 BLOOD CHOLESTEROL INCREASED 20 0.0004
583 GAIT DISTURBANCE 82 0.0004
584 CHOLELITHIASIS 14 0.0004
585 ANAPHYLACTIC SHOCK 11 0.0004
586 DRUG ADMINISTRATION ERROR 13 0.0004
587 DIPLOPIA 11 0.0004
588 INTENTIONAL PRODUCT MISUSE 37 0.0004
589 IMPAIRED QUALITY OF LIFE 6 0.0004
590 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
591 SEIZURE 48 0.0004
592 HYPERTHYROIDISM 6 0.0004
593 VITAMIN D DEFICIENCY 4 0.0004
594 ACCIDENTAL OVERDOSE 15 0.0004
595 MIGRAINE 39 0.0004
596 COELIAC DISEASE 4 0.0004
597 BREATH SOUNDS ABNORMAL 2 0.0004
598 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
599 VOMITING 189 0.0004
600 PALPITATIONS 47 0.0004
601 LETHARGY 23 0.0004
602 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
603 OSTEOPENIA 6 0.0004
604 MEMORY IMPAIRMENT 54 0.0004
605 SLUGGISHNESS 4 0.0004
606 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
607 PRODUCT QUALITY ISSUE 53 0.0004
608 HYPOTENSION 78 0.0004
609 PAIN IN JAW 11 0.0004
610 CONCUSSION 3 0.0004
611 TREATMENT FAILURE 32 0.0004
612 PELVIC FRACTURE 3 0.0004
613 VENTRICULAR EXTRASYSTOLES 4 0.0004
614 PULMONARY HAEMORRHAGE 3 0.0004
615 GASTROINTESTINAL INFLAMMATION 3 0.0004
616 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 21 0.0004
617 CARDIO-RESPIRATORY ARREST 16 0.0004
618 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
619 BLOOD ALBUMIN DECREASED 3 0.0004
620 GINGIVAL PAIN 3 0.0004
621 SENSORY LOSS 3 0.0004
622 NEURALGIA 9 0.0004
623 CHEILITIS 2 0.0004
624 BACK DISORDER 6 0.0004
625 SKIN LACERATION 4 0.0004
626 BLOOD POTASSIUM DECREASED 11 0.0004
627 BLOOD GLUCOSE FLUCTUATION 4 0.0004
628 ASTHENOPIA 2 0.0004
629 DRUG LEVEL INCREASED 6 0.0004
630 MENSTRUAL DISORDER 3 0.0004
631 EMBOLISM 3 0.0004
632 DRUG DOSE OMISSION 59 0.0004
633 HYPERGLYCAEMIA 13 0.0004
634 ACUTE PULMONARY OEDEMA 2 0.0004
635 BLISTER 20 0.0004
636 NAUSEA 280 0.0004
637 SCAB 4 0.0004
638 DRUG-INDUCED LIVER INJURY 11 0.0004
639 PSYCHOLOGICAL TRAUMA 3 0.0003
640 HYSTERECTOMY 3 0.0003
641 HYPOKINESIA 5 0.0003
642 RASH 150 0.0003
643 NEUTROPHIL COUNT DECREASED 14 0.0003
644 BODY TEMPERATURE INCREASED 7 0.0003
645 BLOOD PRESSURE INCREASED 52 0.0003
646 DECREASED INTEREST 2 0.0003
647 ARRHYTHMIA 16 0.0003
648 TOOTH LOSS 7 0.0003
649 CHOLECYSTITIS 4 0.0003
650 HYPERSENSITIVITY 62 0.0003
651 ANAL INCONTINENCE 3 0.0003
652 DYSPNOEA 188 0.0003
653 JOINT SWELLING 40 0.0003
654 THERAPEUTIC RESPONSE DECREASED 20 0.0003
655 VERTIGO 20 0.0003
656 FALL 109 0.0003
657 MEDICATION ERROR 18 0.0003
658 FEELING COLD 9 0.0003
659 HAIR COLOUR CHANGES 4 0.0003
660 NERVOUS SYSTEM DISORDER 10 0.0003
661 POISONING 4 0.0003
662 PRODUCT USE COMPLAINT 5 0.0003
663 CONSTIPATION 69 0.0003
664 INTENTIONAL DOSE OMISSION 9 0.0003
665 ULCER 5 0.0003
666 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
667 SENSORY DISTURBANCE 5 0.0003
668 CHROMATURIA 7 0.0003
669 FEELING HOT 19 0.0003
670 SWELLING 29 0.0003
671 CARDIAC FLUTTER 2 0.0003
672 AUTOIMMUNE DISORDER 3 0.0003
673 JOINT STIFFNESS 8 0.0003
674 SHOCK 7 0.0003
675 DISABILITY 6 0.0003
676 PERICARDIAL EFFUSION 7 0.0003
677 BRADYCARDIA 16 0.0003
678 BLOOD PRESSURE DECREASED 20 0.0003
679 WEIGHT DECREASED 84 0.0003
680 CARDIAC FAILURE ACUTE 2 0.0003
681 DRUG INTOLERANCE 29 0.0003
682 PARAESTHESIA 47 0.0003
683 QUALITY OF LIFE DECREASED 4 0.0003
684 TASTE DISORDER 6 0.0003
685 EYE SWELLING 11 0.0003
686 DRUG LEVEL DECREASED 3 0.0003
687 COMA 14 0.0003
688 CHEST DISCOMFORT 30 0.0003
689 HOSPITALISATION 45 0.0003
690 LIMB DISCOMFORT 9 0.0003
691 MUSCULOSKELETAL DISCOMFORT 5 0.0003
692 PULMONARY OEDEMA 13 0.0003
693 HEADACHE 182 0.0003
694 RESPIRATORY DISTRESS 8 0.0003
695 SYRINGE ISSUE 5 0.0003
696 DEFAECATION URGENCY 2 0.0003
697 SKIN REACTION 4 0.0003
698 RENAL FAILURE ACUTE 12 0.0003
699 CHEST PAIN 52 0.0003
700 DECREASED ACTIVITY 3 0.0003
701 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
702 EYE DISORDER 9 0.0003
703 DECREASED APPETITE 63 0.0003
704 CEREBRAL DISORDER 2 0.0003
705 CONTUSION 26 0.0003
706 TOOTH DISORDER 6 0.0003
707 ABDOMINAL DISTENSION 28 0.0003
708 MALNUTRITION 3 0.0003
709 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
710 TYPE 2 DIABETES MELLITUS 9 0.0003
711 PHOTOPHOBIA 5 0.0003
712 HEPATIC ENZYME INCREASED 18 0.0003
713 FOOT FRACTURE 5 0.0003
714 DISCOMFORT 16 0.0003
715 DRUG DISPENSING ERROR 4 0.0003
716 NEPHROLITHIASIS 12 0.0003
717 SKIN DISCOLOURATION 12 0.0003
718 GYNAECOMASTIA 8 0.0003
719 ELECTROLYTE IMBALANCE 3 0.0003
720 EXPOSURE DURING PREGNANCY 16 0.0003
721 APNOEA 2 0.0003
722 MUSCULAR WEAKNESS 29 0.0003
723 MYALGIA 43 0.0003
724 BLOOD IRON DECREASED 3 0.0003
725 SINUS DISORDER 5 0.0003
726 PREMATURE DELIVERY 4 0.0003
727 HYPERLIPIDAEMIA 3 0.0003
728 UPPER LIMB FRACTURE 5 0.0003
729 HYPOTHYROIDISM 8 0.0003
730 BLOOD DISORDER 2 0.0002
731 OROPHARYNGEAL PAIN 23 0.0002
732 PRESYNCOPE 6 0.0002
733 BLOOD POTASSIUM INCREASED 4 0.0002
734 THROAT IRRITATION 11 0.0002
735 DYSPEPSIA 24 0.0002
736 CARDIOMEGALY 3 0.0002
737 BURNING SENSATION 17 0.0002
738 PULMONARY EMBOLISM 23 0.0002
739 DRUG EFFECT DECREASED 13 0.0002
740 DYSPHONIA 14 0.0002
741 HAEMATEMESIS 6 0.0002
742 HYPOPHAGIA 6 0.0002
743 ERECTILE DYSFUNCTION 6 0.0002
744 GASTRIC DISORDER 8 0.0002
745 URTICARIA 39 0.0002
746 MALAISE 102 0.0002
747 HEPATIC FAILURE 7 0.0002
748 ACUTE KIDNEY INJURY 35 0.0002
749 BEDRIDDEN 3 0.0002
750 BLOOD CALCIUM INCREASED 2 0.0002
751 ORAL CANDIDIASIS 3 0.0002
752 SARS-COV-2 TEST POSITIVE 3 0.0002
753 ABDOMINAL DISCOMFORT 38 0.0002
754 RENAL IMPAIRMENT 19 0.0002
755 LIVER DISORDER 10 0.0002
756 EAR INFECTION 6 0.0002
757 DEHYDRATION 30 0.0002
758 HEPATOTOXICITY 5 0.0002
759 HAIR TEXTURE ABNORMAL 3 0.0002
760 CHRONIC KIDNEY DISEASE 17 0.0002
761 SURGERY 13 0.0002
762 HEART RATE IRREGULAR 5 0.0002
763 PALLOR 6 0.0002
764 C-REACTIVE PROTEIN INCREASED 8 0.0002
765 END STAGE RENAL DISEASE 4 0.0002
766 METABOLIC ACIDOSIS 7 0.0002
767 PERIPHERAL COLDNESS 3 0.0002
768 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
769 DYSURIA 8 0.0002
770 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 39 0.0002
771 NO ADVERSE EVENT 39 0.0002
772 HEPATIC STEATOSIS 4 0.0002
773 APPENDICITIS 2 0.0002
774 ARTERIOSCLEROSIS 2 0.0002
775 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
776 FLATULENCE 12 0.0002
777 VIRAL INFECTION 7 0.0002
778 SKIN DISORDER 7 0.0002
779 DIABETIC KETOACIDOSIS 5 0.0002
780 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
781 FATIGUE 160 0.0002
782 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
783 MENORRHAGIA 4 0.0002
784 PAIN IN EXTREMITY 60 0.0002
785 RASH PRURITIC 11 0.0002
786 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
787 DEEP VEIN THROMBOSIS 13 0.0002
788 PREGNANCY 4 0.0002
789 BLOOD CREATININE INCREASED 13 0.0002
790 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
791 ACNE 15 0.0002
792 INCORRECT DOSE ADMINISTERED 45 0.0002
793 EPILEPSY 6 0.0002
794 HEPATITIS 5 0.0002
795 THYROID DISORDER 3 0.0002
796 DRUG WITHDRAWAL SYNDROME 17 0.0002
797 SKIN ULCER 5 0.0002
798 HEPATIC FUNCTION ABNORMAL 7 0.0002
799 HOT FLUSH 14 0.0002
800 RHINORRHOEA 12 0.0002
801 ABDOMINAL PAIN UPPER 38 0.0002
802 PRODUCT DOSE OMISSION 12 0.0002
803 MULTIPLE FRACTURES 3 0.0002
804 PHOTOSENSITIVITY REACTION 3 0.0002
805 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
806 RENAL FAILURE 24 0.0002
807 EXPIRED PRODUCT ADMINISTERED 6 0.0002
808 BLOOD CALCIUM DECREASED 2 0.0002
809 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
810 VISUAL IMPAIRMENT 22 0.0002
811 CEREBROVASCULAR ACCIDENT 30 0.0002
812 CIRCULATORY COLLAPSE 3 0.0002
813 SCAR 3 0.0002
814 CHOLECYSTECTOMY 2 0.0002
815 MULTI-ORGAN FAILURE 3 0.0002
816 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
817 MUSCULOSKELETAL PAIN 9 0.0002
818 HYPERKALAEMIA 6 0.0002
819 CARDIAC DISORDER 16 0.0002
820 HYPOXIA 6 0.0002
821 LYMPHOCYTE COUNT DECREASED 3 0.0002
822 DRUG ERUPTION 3 0.0002
823 BLOOD PRESSURE FLUCTUATION 4 0.0002
824 GASTROENTERITIS VIRAL 3 0.0002
825 LACRIMATION INCREASED 5 0.0002
826 COVID-19 29 0.0002
827 BURSITIS 2 0.0002
828 ADRENAL INSUFFICIENCY 2 0.0002
829 URINARY TRACT INFECTION 28 0.0002
830 NEUTROPENIA 22 0.0002
831 DRUG DEPENDENCE 26 0.0002
832 CYST 2 0.0002
833 BONE DENSITY DECREASED 5 0.0002
834 EYE PAIN 9 0.0002
835 FRACTURE 3 0.0002
836 BLOOD URINE PRESENT 3 0.0002
837 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
838 LOWER LIMB FRACTURE 3 0.0002
839 ACUTE RESPIRATORY FAILURE 3 0.0002
840 ERUCTATION 3 0.0002
841 LACTIC ACIDOSIS 5 0.0002
842 HAEMATOMA 4 0.0002
843 ORAL HERPES 3 0.0002
844 CHILLS 18 0.0002
845 PRURITUS 59 0.0002
846 SKIN FISSURES 3 0.0002
847 PYREXIA 53 0.0002
848 GASTRITIS 4 0.0002
849 HAEMATOCRIT DECREASED 3 0.0002
850 BLOOD PRESSURE ABNORMAL 3 0.0002
851 GAIT INABILITY 5 0.0001
852 MENSTRUATION IRREGULAR 4 0.0001
853 MYOCARDIAL INFARCTION 26 0.0001
854 PAIN 90 0.0001
855 RASH ERYTHEMATOUS 7 0.0001
856 MULTIPLE SCLEROSIS 7 0.0001
857 ASTHENIA 55 0.0001
858 SKIN LESION 4 0.0001
859 INFLUENZA 16 0.0001
860 HAEMOPTYSIS 4 0.0001
861 CARPAL TUNNEL SYNDROME 2 0.0001
862 ALOPECIA 28 0.0001
863 HEART RATE DECREASED 5 0.0001
864 ABDOMINAL PAIN 33 0.0001
865 ASTHMA 16 0.0001
866 LYMPHADENOPATHY 5 0.0001
867 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
868 IRRITABLE BOWEL SYNDROME 3 0.0001
869 RECTAL HAEMORRHAGE 6 0.0001
870 ANGINA PECTORIS 4 0.0001
871 HYPOACUSIS 6 0.0001
872 ANOSMIA 2 0.0001
873 PRODUCT PRESCRIBING ISSUE 3 0.0001
874 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
875 THERAPY CESSATION 7 0.0001
876 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
877 BRONCHITIS 10 0.0001
878 WHEEZING 8 0.0001
879 CORONARY ARTERY DISEASE 4 0.0001
880 BLOOD COUNT ABNORMAL 2 0.0001
881 ANKLE FRACTURE 2 0.0001
882 INJURY 9 0.0001
883 BRAIN FOG 2 0.0001
884 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
885 ILLNESS 13 0.0001
886 BACK PAIN 29 0.0001
887 NIGHT SWEATS 4 0.0001
888 DIARRHOEA 80 0.0001
889 RESPIRATORY FAILURE 9 0.0001
890 FIBROMYALGIA 3 0.0001
891 BLINDNESS 5 0.0001
892 LIVER INJURY 3 0.0001
893 INFLUENZA LIKE ILLNESS 10 0.0001
894 STAPHYLOCOCCAL INFECTION 4 0.0001
895 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
896 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
897 CANDIDA INFECTION 2 0.0001
898 ARTHRALGIA 49 0.0001
899 INFLAMMATION 6 0.0001
900 PANCREATITIS 6 0.0001
901 DEATH 97 0.0001
902 GASTROINTESTINAL DISORDER 10 0.0001
903 MOBILITY DECREASED 8 0.0001
904 NASOPHARYNGITIS 20 0.0001
905 BLOOD GLUCOSE ABNORMAL 2 0.0001
906 FLUSHING 11 0.0001
907 ARTHROPATHY 6 0.0001
908 SINUSITIS 11 0.0001
909 ERYTHEMA 22 0.0001
910 COUGH 30 0.0001
911 EPISTAXIS 8 0.0001
912 PRODUCT USE ISSUE 20 0.0001
913 INTESTINAL OBSTRUCTION 4 0.0001
914 OCULAR HYPERAEMIA 5 0.0001
915 NEUROPATHY PERIPHERAL 10 0.0001
916 RED BLOOD CELL COUNT DECREASED 3 0.0001
917 PERIPHERAL SWELLING 16 0.0001
918 PLATELET COUNT DECREASED 11 0.0001
919 ACUTE MYOCARDIAL INFARCTION 3 0.0001
920 ARTHRITIS 8 0.0001
921 PREMATURE BABY 3 0.0001
922 THROMBOCYTOPENIA 11 0.0001
923 ECZEMA 5 0.0001
924 HIP FRACTURE 3 0.0001
925 DEVICE DISLOCATION 4 0.0001
926 EMOTIONAL DISTRESS 11 0.0001
927 APPLICATION SITE PAIN 2 0.0001
928 VISUAL ACUITY REDUCED 3 0.0001
929 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
930 PANCYTOPENIA 5 0.0001
931 NECK PAIN 5 0.0001
932 HAEMATURIA 3 0.0001
933 PNEUMONIA 28 0.0001
934 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
935 HAEMORRHAGE 9 0.0001
936 RENAL DISORDER 4 0.0001
937 RASH MACULAR 3 0.0001
938 BONE PAIN 5 0.0001
939 NASAL CONGESTION 5 0.0001
940 PRODUCT ADHESION ISSUE 3 0.0001
941 PLEURAL EFFUSION 5 0.0001
942 CEREBRAL INFARCTION 2 0.0001
943 DRY EYE 4 0.0001
944 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
945 COLITIS 3 0.0001
946 CARDIOVASCULAR DISORDER 2 0.0001
947 PLASMA CELL MYELOMA 3 0.0001
948 PSORIATIC ARTHROPATHY 3 0.0001
949 ANAEMIA 14 0.0001
950 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
951 OSTEOPOROSIS 3 0.0001
952 DEVICE MALFUNCTION 5 0.0001
953 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
954 ILL-DEFINED DISORDER 4 0.0001
955 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
956 PRODUCT DOSE OMISSION ISSUE 19 0.0001
957 PRODUCTIVE COUGH 3 0.0001
958 CYSTITIS 2 0.0001
959 BLOOD GLUCOSE DECREASED 3 0.0001
960 CARDIAC FAILURE 5 0.0001
961 CARDIAC FAILURE CONGESTIVE 5 0.0001
962 THROMBOSIS 5 0.0001
963 ATRIAL FIBRILLATION 6 0.0001
964 PSORIASIS 8 0.0001
965 NEOPLASM MALIGNANT 4 0.0001
966 HAEMOGLOBIN DECREASED 6 0.0001
967 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
968 HAEMATOCHEZIA 3 0.0001
969 OXYGEN SATURATION DECREASED 3 0.0001
970 EYE IRRITATION 3 0.0001
971 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
972 CATARACT 3 0.0001
973 ABORTION SPONTANEOUS 2 0.0000
974 INFECTION 7 0.0000
975 SKIN EXFOLIATION 4 0.0000
976 PRODUCT STORAGE ERROR 4 0.0000
977 DRY SKIN 6 0.0000
978 COLITIS ULCERATIVE 2 0.0000
979 INJECTION SITE REACTION 3 0.0000
980 BREAST CANCER 4 0.0000
981 THERAPY INTERRUPTED 3 0.0000
982 SKIN BURNING SENSATION 3 0.0000
983 INJECTION SITE SWELLING 3 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
985 SEPSIS 4 0.0000
986 INJECTION SITE PAIN 10 0.0000
987 INJECTION SITE ERYTHEMA 3 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000